Evidence map›Paper›PMID 38478185›Full record

ArticleHernia : the journal of hernias and abdominal wall surgery2024

Long-term results with biosynthetic absorbable P4HB mesh in ventral abdominal wall repair: a multicentre analysis.

J Bueno-Lledó, B Porrero-Guerrero, F Ferreira, M J Peña-Soria, M Sanz-Sánchez, A Mansilla-Roselló, R Souto, R Rejón-López, S Pous-Serrano

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Hernia : the journal of hernias and abdominal wall surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

J Bueno-LledóUnit of Abdominal Wall Surgery, Department of Digestive Surgery, Hospital Universitari I Poltecnic La Fe, Fernando Abril Martorell, 106, 46026, Valencia, Spain. buenolledo@hotmail.com.ORCID 0000-0002-3116-5022
B Porrero-GuerreroDepartment of Digestive Surgery, Hospital Universitario Ramón y Cajal, Madrid, Spain.
F FerreiraComplex Abdominal Wall Unit, ULS Hospital Pedro Hispano, Matosihnos, Portugal.
M J Peña-SoriaHospital Clínico Universitario San Carlos, Madrid, Spain.
M Sanz-SánchezHospital Universitario Gregorio Marañón, Madrid, Spain.
A Mansilla-RosellóUnit of Abdominal Wall Surgery, Hospital Universitario Virgen de Las Nieves, Granada, Spain.
R SoutoUnit of Abdominal Wall Surgery, Hospital Garcia de Orta, Almada, Portugal.
R Rejón-LópezUnit of Abdominal Wall Surgery, Hospital Universitario Virgen de Las Nieves, Granada, Spain.
S Pous-SerranoUnit of Abdominal Wall Surgery, Department of Digestive Surgery, Hospital Universitari I Poltecnic La Fe, Fernando Abril Martorell, 106, 46026, Valencia, Spain.
Hospital Universitari i Politècnic La Fe · ESHospital Universitario Virgen de las Nieves · ESHospital Clínico San Carlos · ESHospital Garcia de Orta · PTHospital General Universitario Gregorio Marañón · ESHospital Pedro Hispano · PTHospital Universitario Ramón y Cajal · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this multicentre study was to analyse the outcomes of biosynthetic absorbable poly-4-hydroxybutyrate (P4HB) prosthesis implantation in patients undergoing ventral hernia repair (VHR) in the context of different degrees of contamination.

methodsFrom May 2016 to December 2021, a multicentre retrospective analysis of patients who underwent elective or urgent hernia repair with P4HB prosthesis was performed in seven hospitals in Spain and Portugal. Patients with a postoperative follow-up of less than 20 months and those within the theoretical period of prosthesis resorption were excluded from the study. Regarding the degree of contamination, patients were assessed according to the modified Ventral Hernia Working Group (VHWG) classification. Epidemiological data, hernia characteristics, surgical and postoperative variables (Clavien-Dindo classification) of these patients were analyzed. Risk factors related to long-term recurrence were studied by a multivariate analysis.

resultsIn 236 cases of P4HB prosthesis implantation, repair in cases of Grade 3 was the most frequent (49.1%), followed by Grade 2 in 42.3% of cases and Grade 1 in 8.4%. The most frequent complications were Grade 1, with the majority occurring during the first year. The overall rate of surgical site occurrences (SSO) was 30%. The hernia recurrence rate was 14.4% (n = 34), with a mean postoperative follow-up time of 41 months (22-61). The multivariate analysis showed that the onlay location of the mesh (OR 1.07; CI 1.42-2.70, p = 0.004) was a significant independent risk factor for recurrence.

conclusionsThe use of a P4HB bioresorbable mesh for the VHR with different degrees of contamination leads to favourable results overall, with an acceptable rate of hernia recurrence. The onlay location of the P4HB prosthesis is the main factor in recurrence in both elective and emergency settings.

Indexed as

Absorbable ImplantsHernia, VentralHerniorrhaphySurgical MeshAdultAgedFemaleHumansHydroxybutyratesMaleMiddle AgedPolyestersPostoperative ComplicationsRecurrenceRetrospective StudiesHydroxybutyratespoly(4-hydroxybutanoate)PolyestersBiosynthetic meshChronic mesh infectionP4HB scaffoldPhasix meshRecurrenceSurgical site occurrencesVentral herniaVHWG classification

Identifiers

PMID38478185
OpenAlexW4392751986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.